IPP Bureau
Gland Pharma receives USFDA’s tentative approval for Latanoprostene Bunod Ophthalmic Solution
By IPP Bureau - July 24, 2024
The product is bioequivalent and therapeutically equivalent to the reference listed drug
Shilpa Biologicals receives registration approval for Adalimumab from Morocco, MoH
By IPP Bureau - July 24, 2024
Shilpa Biologicals has developed high concentration adalimumab (100 mg/mL)
Zydus receives USFDA’s final approval for Valsartan Tablets
By IPP Bureau - July 24, 2024
The drug will be manufactured at the group's formulation manufacturing facility in Ahmedabad SEZ - II, India
Thyrocare Technologies posts Q1 FY25 consolidated profit at Rs. 24.17 Cr
By IPP Bureau - July 24, 2024
Thyrocare Technologies has reported total income of Rs. 160.53 crores during the period ended June 30, 2024
Torrent Pharmaceuticals posts Q1 FY25 consolidated PAT at Rs. 457 Cr
By IPP Bureau - July 24, 2024
Torrent Pharmaceuticals has reported total income of Rs. 2,883 crores during the period ended June 30, 2024
Syngene reports drop in Q1 FY25 revenue to Rs. 790 Cr
By IPP Bureau - July 24, 2024
Reported profit after tax declined 19% year-on-year to Rs 76 crores
USFDA successfully inspects Carbogen Amcis’s manufacturing sites in Neuland and Aarau
By IPP Bureau - July 24, 2024
The inspections concluded with no Form 483 observations or significant critical findings
Poly Medicure posts Q1 FY25 consolidated PAT at Rs. 74.03 Cr
By IPP Bureau - July 23, 2024
Poly Medicure has reported total income of Rs. 401.69 crores during the period ended June 30, 2024
Solara Active Pharma Sciences reports Q1 FY25 consolidated loss at Rs. 13.46 Cr
By IPP Bureau - July 23, 2024
Solara Active Pharma Sciences has reported total income of Rs. 364.05 crores during the period ended June 30, 2024
Biolyst Scientific announced as new brand name to encompass EMS and Azer
By IPP Bureau - July 23, 2024
The integrated company delivers a broad portfolio of over 30,000 lab products across microscopy, histology, and other research areas
Caplin Steriles gets USFDA approval for Ephedrine Sulfate injection USP
By IPP Bureau - July 23, 2024
Ephedrine Sulfate injection USP, 50 mg/mL is indicated for the treatment of clinically important hypotension
RPG Life Sciences posts Q1 FY25 PAT higher at Rs. 26.76 Cr
By IPP Bureau - July 23, 2024
RPG Life Sciences has reported total income of Rs. 167.79 crores during the period ended June 30, 2024
Meitheal acquires Contepo from Nabriva Therapeutics to expand specialty biopharmaceuticals portfolio
By IPP Bureau - July 23, 2024
Contepo offers a unique mechanism of action and has the potential to address increasing antibiotic resistance and gaps in the current antibiotic treatment landscape
